Skip to content

Clinical trials

Phase 2 Cytomegalovirus Infections trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytomegalovirus Infections Phase: Phase 2 Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20121
20131
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cell Medica Ltd1
Genentech, Inc.1
Gilead Sciences1
Hookipa Biotech GmbH1
National Institute of Allergy and Infectious Diseases (NIAID)1
Professor Lorraine Harper1
University College, London1
University Hospital Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytomegalovirus Infections8
Acquired Immunodeficiency Syndrome1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Cytomegalovirus Retinitis1
Graft vs Host Disease1
HIV Infections1
Hearing Loss1
Retinitis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.